• Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears

    Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears
    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon GroupBy Gina ShawDrug manufacturers have begun enforcing their 340B claims data policies, moving pharmacies with unvalidated purchases into
  • Highlights in HD Testing, Patient Monitoring, and Inventory Management

    Highlights in HD Testing, Patient Monitoring, and Inventory Management
    By Marcus A. BanksThe ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas, featured technologies to improve hazardous drug sampling, enhance real-time response to patient emergencies, and provide more customized high-density storage.BD, ChemoGLO Streamline Hazardous Drug TestingBD and ChemoGLO now offer streamlined hazardous drug detection that only requires one wipe sample per location for all analyses, rather than having to use different collection kits and wiping side by side.Th

Follow @newsl_pharmacy on Twitter!